CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
DOD Biotech PCL Company Snapshot
DOD Biotech PCL operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares DOD Biotech PCL with three other pharmaceutical manufacturers in Asia: RPG Life Sciences Limited of INDIA (2020 sales of 3.76 billion Indian Rupees [US$51.19 million] ), Mekophar Chemical Pharma JSC of VIETNAM (1.21 trillion Vietnamese Dong [US$52.78 million] ), and Caregen Co Ltd which is based in KOREA (SOUTH) (60.30 billion Korean Won [US$53.90 million] of which 100% was Cosmeceuticals&Dermal Filler).

Sales Analysis. During the first quarter of 2021, sales at DOD Biotech PCL totalled 411.90 million Thai Bahts . This is an increase of 20.6% from the 341.60 million Thai Bahts in sales at the company during the first quarter of 2020. During the previous 7 quarters, sales at DOD Biotech PCL have increased compared with the same quarter in the previous year. DOD Biotech PCL reported sales of 1.61 billion Thai Bahts (US$51.72 million) for the year ending December of 2020. This represents an increase of 104.0% versus 2019, when the company's sales were 789.92 million Thai Bahts . This was the fourth straight year of sales growth at DOD Biotech PCL. Sales of Supplementary Business saw an increase of 107.3% in 2020, from 551.18 million Thai Bahts to 1.14 billion Thai Bahts .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
DOD Biotech PCL
  Stock Performance Chart for DOD Biotech PCL
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 13.40
(Figures in Thai Bahts )
1 Week -1.5%   13 Weeks 4.7%  
4 Weeks 0.0%   52 Weeks 92.8%  
 
DOD Biotech PCL Key Data:
  Ticker: DOD Country: Thailand
  Exchanges: BAN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2020 Sales 1,611,200,876
(Year Ending Jan 2021).
Employees: 347
  Currency: Thai Bahts Market Cap: 5,494,000,000
  Fiscal Yr Ends: December Shares Outstanding: 410,000,000
  Share Type: Ordinary Closely Held Shares: 247,471,800
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.